This release presents TLMM v6.7, an empirical validation and calibration refinement extension of the Topological Latent Manifold Model. Building on TLMM v6.6, this version introduces five major methodological advances: (1) cross-cohort longitudinal validation across synthetic ADNI-, AIBL-, and OASIS-like cohorts, demonstrating progressive improvement in transportability and generalization; (2) adaptive viability threshold estimation, replacing the fixed viability threshold with individual- and cohort-level Bayesian posterior distributions to improve calibration and uncertainty quantification; (3) Counterfactual Delay Effect (CDE) analysis, a new framework for quantifying the projected viability cost of delaying intervention under individualized counterfactual scenarios; (4) the ABF–TLMM Joint Latent Bridge, integrating Appearance–Behavior Framework (ABF) dynamics with TLMM viability trajectories in a shared biologically constrained latent space; and (5) a comprehensive falsifiability test battery (C1–C6) for systematic stress-testing of causal assumptions, transportability, calibration, subgroup consistency, and model robustness. TLMM v6.7 extends the framework beyond causal personalization by introducing explicit timing-sensitive intervention analysis and adaptive calibration mechanisms. The new adaptive threshold model improves Personalized Viability Horizon (PVH) calibration, reduces expected calibration error, improves interval coverage, and enables more individualized risk assessment. The Counterfactual Delay Effect framework further expands the intervention modeling layer by estimating the projected loss associated with delayed action, providing a structured basis for timing-aware decision support. The ABF–TLMM Joint Latent Bridge serves as a pilot architecture toward future biological and behavioral integration planned for TLMM v7.0. The shared latent-space formulation allows appearance-related signals, behavioral dynamics, viability trajectories, threshold mechanisms, and individual heterogeneity to be represented within a unified probabilistic framework. Illustrative synthetic experiments demonstrate improved predictive performance relative to single-module approaches while maintaining interpretability. This release includes the complete manuscript, all figures (Fig.1–Fig.17), and the accompanying demonstration code used to generate the illustrative synthetic visualizations. All figures and numerical results are illustrative synthetic demonstrations and are not derived from real patient data. TLMM v6.7 is intended as a methodological research framework for viability forecasting, causal reasoning, uncertainty quantification, and model validation research. It is not a diagnostic tool, treatment recommendation system, or clinical decision-support device.
Koji Okino (Sun,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: